Pressor agents in cardiogenic shock.
D000818:Animals; D001002:Anuria / Q000209:etiology; D001021:Aortic Valve / Q000601:surgery; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003097:Collateral Circulation; D003331:Coronary Vessels / Q000187:drug effects; D003911:Dextrans / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004285:Dogs; D004298:Dopamine / Q000627:therapeutic use; D004837:Epinephrine / Q000097:blood; D006331:Heart Diseases / Q000188:drug therapy*; D006350:Heart Valve Prosthesis; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007511:Ischemia; D007773:Lactates / Q000097:blood; D008680:Metaraminol / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage; D009638:Norepinephrine / Q000097:blood / Q000627:therapeutic use; D010101:Oxygen Consumption / Q000187:drug effects; D010643:Phenoxybenzamine / Q000008:administration & dosage; D012769:Shock / Q000188:drug therapy*; D012867:Skin / Q000098:blood supply; D013696:Temperature; D013997:Time Factors; D014261:Tricuspid Valve / Q000601:surgery; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D003911:Dextrans; D004071:Digitalis Glycosides; D007773:Lactates; D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D008680:Metaraminol; D004298:Dopamine; D006854:Hydrocortisone; D009638:Norepinephrine; D008775:Methylprednisolone; D004837:Epinephrine